Candin Safety & Efficacy Study for the Treatment of Warts

NCT01757392 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Warts
Human Papilloma Virus

Interventions

BIOLOGICAL: Candida albicans Skin Test Antigen

Sponsor

Nielsen BioSciences, Inc.